NanJing Pharmaceutical Company Limited

Shanghai Stock Exchange 600713.SS

NanJing Pharmaceutical Company Limited Free Cash Flow for the year ending December 31, 2023: USD 246.23 M

NanJing Pharmaceutical Company Limited Free Cash Flow is USD 246.23 M for the year ending December 31, 2023, a 302.87% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

NanJing Pharmaceutical Company Limited Free Cash Flow for the year ending December 31, 2022 was USD -121.38 M, a -298.36% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow for the year ending December 31, 2021 was USD 61.19 M, a 128.54% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow for the year ending December 31, 2020 was USD -214.39 M, a -312.30% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow for the year ending December 31, 2019 was USD 100.99 M, a 202.38% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 600713.SS

NanJing Pharmaceutical Company Limited

CEO	Mr. Liang Zhang
IPO Date	July 1, 1996
Location	China
Headquarters	Building A
Employees	4,903
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale

Description

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Key trends

Past 5 years